HomeAI · summaries
Storia in 18 fonti
Moderna shares surge after it says experimental mRNA cancer treatment passed key test
Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine called intismeran that is designed to be tailored to individual patients based on unique mutations within their tumors.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
en.mercopress.com
A personalized mRNA therapy passes a phase 3 melanoma trial for the first time
Pharmaceutical companies Merck, known as MSD outside the United States and Canada, and Moderna announced on Wednesday that their individualized neoantigen therapy, intismeran…
- ·
timesofisrael.com
‘Breakthrough’ Moderna personalized mRNA cancer vaccine curbs melanoma reoccurrence
News of first positive large late-stage trial result for drug could signal new era for treating solid-tumor cancers, with tests underway for lung, breast and pancreatic cancers
